Status: Recruiting
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
The primary purpose of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's disease.
Participants needed: 150
Trial details
Phase: Phase 4Age: 50+Biological sex: AllType: InterventionalSponsor: Alpha Cognition, IncUpdated: Sep 25, 2026Locations: 20
Eligibility criteria
Male and female outpatients aged 50 years and greater at the time of informed co... [+13]
Dementia due to causes other than Alzheimer's disease, including but not limited... [+20]